{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:06:46Z","timestamp":1780553206250,"version":"3.54.1"},"reference-count":47,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In an effort to prevent opioid overdose mortality among Veterans, Department of Veterans Affairs (VA) facilities began implementing opioid overdose education and naloxone distribution (OEND) in 2013 and a national program began in 2014. VA is the first national health care system to implement OEND. The goal of this study is to examine patient perceptions of OEND training and naloxone kits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Four focus groups were conducted between December 2014 and February 2015 with 21 patients trained in OEND. Participants were recruited from a VA residential facility in California with a substance use disorder treatment program (mandatory OEND training) and a homeless program (optional OEND training). Data were analyzed using matrices and open and closed coding approaches to identify participants\u2019 perspectives on OEND training including benefits, concerns, differing opinions, and suggestions for improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Veterans thought OEND training was interesting, novel, and empowering, and that naloxone kits will save lives. Some veterans expressed concern about using syringes in the kits. A few patients who never used opioids were not interested in receiving kits. Veterans had differing opinions about legal and liability issues, whether naloxone kits might contribute to relapse, and whether and how to involve family in training. Some veterans expressed uncertainty about the effects of naloxone. Suggested improvements included active learning approaches, enhanced training materials, and increased advertisement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>OEND training was generally well received among study participants, including those with no indication for a naloxone kit. Patients described a need for OEND and believed it could save lives. Patient feedback on OEND training benefits, concerns, opinions, and suggestions provides important insights to inform future OEND training programs both within VA and in other health care settings. Training is critical to maximizing the potential for OEND to save lives, and this study includes specific suggestions for improving the effectiveness and acceptability of training.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2015.1129528","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T20:43:14Z","timestamp":1450298594000},"page":"118-126","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":31,"title":["Patient Perspectives on An Opioid Overdose Education and Naloxone Distribution Program in the U.S. Department of Veterans Affairs"],"prefix":"10.1177","volume":"37","author":[{"given":"Elizabeth M.","family":"Oliva","sequence":"first","affiliation":[{"name":"Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, California, USA"},{"name":"Program Evaluation and Resource Center, VA Office of Mental Health Operations, Menlo Park, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nevedal","sequence":"additional","affiliation":[{"name":"Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor T.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, California, USA"},{"name":"Program Evaluation and Resource Center, VA Office of Mental Health Operations, Menlo Park, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"McCaa","sequence":"additional","affiliation":[{"name":"Center for Innovation to Implementation, VA Palo Alto Health Care System, Menlo Park, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Cochran","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA"},{"name":"VA Palo Alto Health Care System, Menlo Park, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Eric","family":"Konicki","sequence":"additional","affiliation":[{"name":"Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA"},{"name":"Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey S.","family":"Davis","sequence":"additional","affiliation":[{"name":"Network for Public Health Law, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wilder","sequence":"additional","affiliation":[{"name":"Cincinnati VA Medical Center, Cincinnati, Ohio, USA"},{"name":"Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"Warner M Hedegaard H Chen L. Trends in Drug-poisoning Deaths Involving Opioid Analgesics and Heroin: United States 1999\u20132012. NCHS Health E-Stat. Available at: http:\/\/www.cdc.gov\/nchs\/data\/hestat\/drug_poisoning\/drug_poisoning_deaths_1999-2012.pdf. Published December 2014. Accessed August 1 2015."},{"key":"e_1_3_4_3_2","unstructured":"Hedegaard H Chen L Warner M. Drug-Poisoning Deaths Involving Heroin: United States 2000\u20132013. NCHS Data Brief no 190. Available at: http:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db190.pdf. Published 2015. Accessed August 1 2015."},{"key":"e_1_3_4_4_2","volume-title":"The Facts Hurt: A State-By-State Injury Prevention Policy Report 2015","author":"Levi J","year":"2015","unstructured":"Levi J, , Segal L, , Martin A. The Facts Hurt: A State-By-State Injury Prevention Policy Report 2015. Washington, DC: Trust for America's Health, Robert Wood Johnson Foundation; 2015."},{"key":"e_1_3_4_5_2","first-page":"32","article-title":"Rates of deaths from drug poisoning and drug poisoning involving opioid analgesics\u2014United States 1999\u20132013","volume":"64","author":"Chen LH","year":"2015","unstructured":"Chen LH, , Hedegaard H, , Warner M. Rates of deaths from drug poisoning and drug poisoning involving opioid analgesics\u2014United States 1999\u20132013. MMWR Morb Mortal Wkly Rep. 2015;64:32.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318202aa27"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-1-201301010-00013"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2015.1037530"},{"key":"e_1_3_4_9_2","volume-title":"SAMHSA Opioid Overdose Prevention Toolkit","author":"Substance Abuse and Mental Health Services Administration","year":"2013","unstructured":"Substance Abuse and Mental Health Services Administration. SAMHSA Opioid Overdose Prevention Toolkit. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013. HHS Publication No. (SMA) 13-4742."},{"key":"e_1_3_4_10_2","volume-title":"Opioid Overdose: Preventing and Reducing Opioid Overdose Mortality","author":"United Nations Office on Drugs and Crime","year":"2013","unstructured":"United Nations Office on Drugs and Crime. Opioid Overdose: Preventing and Reducing Opioid Overdose Mortality. New York: United Nations; 2013."},{"key":"e_1_3_4_11_2","volume-title":"Community Management of Opioid Overdose","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Community Management of Opioid Overdose. Geneva, Switzerland: World Health Organization; 2014."},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg032"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02314.x"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n03_11"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826080701801261"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jti053"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2008.03.002"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.01.003"},{"key":"e_1_3_4_19_2","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons\u2014United States","volume":"64","author":"Wheeler E","year":"2014","unstructured":"Wheeler E, , Jones TS, , Gilbert MK, , Davidson PJ. Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:631\u2013635.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_20_2","first-page":"101","article-title":"Community-based opioid overdose prevention programs providing naloxone\u2014United States","volume":"61","author":"Wheeler E","year":"2010","unstructured":"Wheeler E, , Davidon PJ, , Jones TS, , Florenze KS. Community-based opioid overdose prevention programs providing naloxone\u2014United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:101\u2013105.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_21_2","unstructured":"Role of Naloxone in Opioid Overdose Fatality Prevention. Food and Drug Administration Center for Drug Evaluation and Research Office of the Assistant Secretary for Health National Institute on Drug Abuse; and the Centers for Disease Control and Prevention. http:\/\/www.fda.gov\/Drugs\/NewsEvents\/ucm277119.htm. Public Workshop. April 12 2012."},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-1-201301010-00003"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-006-9120-z"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-015-3394-3"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jtg031"},{"key":"e_1_3_4_27_2","article-title":"Reducing drug related deaths: a pre-implementation assessment of knowledge,barriers and enablers for naloxone distribution through general practice","author":"Matheson C","unstructured":"Matheson C, , Pflanz-Sinclair C, , Aucott L, . Reducing drug related deaths: a pre-implementation assessment of knowledge,barriers and enablers for naloxone distribution through general practice. BMC Fam Pract. 2014;15:12. doi:10.1186\/1471-2296-15-12","journal-title":"BMC Fam Pract"},{"key":"e_1_3_4_28_2","article-title":"Naloxone-does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin\/opioid overdose","author":"Neale J","unstructured":"Neale J, , Strang J. Naloxone-does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin\/opioid overdose. Addiction. 2015;110(10):1644-52. doi:10.1111\/add.13027","journal-title":"Addiction"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0017896914550321"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-99"},{"key":"e_1_3_4_31_2","volume-title":"The Focus Group Guidebook","author":"Morgan DL.","year":"1997","unstructured":"Morgan DL. The Focus Group Guidebook. Thousand Oaks, CA: Sage Publications; 1997."},{"key":"e_1_3_4_32_2","volume-title":"Qualitative Data Analysis: A Methods Sourcebook","author":"Miles MB, Huberman AM, Salda\u00f1a J","year":"2013","unstructured":"Miles MB, Huberman AM, Salda\u00f1a J. Qualitative Data Analysis: A Methods Sourcebook. Thousand Oaks, CA: Sage Publications; 2013."},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-014-3143-z"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.370"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02025.x"},{"key":"e_1_3_4_36_2","first-page":"348","article-title":"Lapse, relapse and survival among opiate addicts after treatment","volume":"154","author":"Gossop M","year":"1989","unstructured":"Gossop M, , Green L, , Phillips G, , Bradley B. Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study. Br J Psychiatry. 1989;154:348\u2013353.","journal-title":"A prospective follow-up study. Br J Psychiatry."},{"key":"e_1_3_4_37_2","volume-title":"Consideration of Naloxone","year":"2012","unstructured":"Advisory Council on the Misuse of Drugs. Consideration of Naloxone. London: Advisory Council on the Misuse of Drugs; 2012."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/jlme.12208"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-297"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2005.07.020"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9421993.x"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","unstructured":"Humphreys K. An Overdose Antidote Goes Mainstream. Health Aff. (Millwood). 2015;34:1624\u20131627. Available at: http:\/\/content.healthaffairs.org\/content\/34\/10\/1624.full.html. Accessed October 10 2015.","DOI":"10.1377\/hlthaff.2015.0934"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.10.013"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302638"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12485"},{"key":"e_1_3_4_46_2","unstructured":"American Society of Anesthesiologists. Opioid Overdose Resuscitation Card. Accessed 2\/26\/16. https:\/\/www.asahq.org\/WhenSecondsCount\/resources.aspx"},{"key":"e_1_3_4_47_2","unstructured":"Wheeler M Monks A. Narcan saves lives: I am the evidence\u2013Brian. https:\/\/www.youtube.com\/watch?v=L1lyaOoXZ0E. We Are the Evidence: Massachusetts."},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.05.053"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2015.1129528","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2015.1129528","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2015.1129528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:46:59Z","timestamp":1777625219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2015.1129528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1080\/08897077.2015.1129528"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2015.1129528","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}